BioSpace News Archive

SCG Cell Therapy Pte Ltd, a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, has celebrated the official opening of its Cell Therapy cGMP Manufacturing Facility and R&D Centre at its headquarters in Singapore.

Onkos Surgical announced its launch of the JTS Extendible Prosthesis, a novel growing implant designed for pediatric patients with bone cancer, and unveiled its new, state-of-the-art manufacturing and R&D innovation center at its Parsippany, NJ headquarters to support the integration and growth of the technology.

Aviceda Therapeutics announces upcoming presentations about its lead ophthalmic clinical asset, AVD-104, a novel glycan-coated nanoparticle for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Oculis Holding AG today announced that Riad Sherif, MD, CEO of Oculis, will participate at OIS Retina Innovation Summit , an event organized by Ophthalmology Innovation Source, on July 27, in Seattle, Washington.

Emergex Vaccines Holding Limited today announced the successful completion of naNO-COVID, a Phase I clinical trial in Switzerland investigating the safety and reactogenicity of CoronaTcP™1 in healthy volunteers.

scPharmaceuticals Inc. today announced that on July 3, 2023, the Compensation Committee of scPharmaceuticals’ board of directors granted inducement equity grants consisting of stock options to purchase an aggregate of 26,250 shares of its common stock to seven new employees.

MEI Pharma, Inc. (NASDAQ: MEIP) (the “Company”) today reminded shareholders to vote FOR the pending transaction with Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity”) in connection with the Company’s special meeting on July 23, 2023.

FOXO Technologies Inc. today announced the launch of its cutting-edge Bioinformatics Services to accelerate breakthroughs in biology, biotechnology, and healthcare, and redefine the growing field of epigenetic research.

Reveal Lasers LLC is pleased to announce its recent acquisition of the AgeJET Advanced Plasma Skin Therapy device through a strategic merger with NEOconcepts LLC.

Zymeworks Inc. today announced that management will report its second quarter 2023 financial results after market close on August 10, 2023.